{"success":true,"data":{"pressRelease":{"id":"105416","rtpr_id":"nGNXCH9pk","ticker":"PRPO","exchange":"NASDAQ","all_tickers":["PRPO"],"title":"Precipio Announces Q2-2026 Shareholder Update Call","author":"Globe Newswire","published_at":"2026-07-31T20:00:00.102Z","article_body":"NEW HAVEN, Conn., July 31, 2026 (GLOBE NEWSWIRE) -- Specialty cancer\ndiagnostics company Precipio, Inc.\n(https://www.globenewswire.com/Tracker?data=JIzv5TjhHQvDJRqmKR07o2JyQAJlnCigcFgzVo-RZPjscKB9n7Vy5ZJZ-0ZNZXbnLXCepj68EdRCyV8nRlR1wWhloPZOME0efJDddtf_SrQ=) (NASDAQ:\nPRPO)\n(https://www.globenewswire.com/Tracker?data=TkyaefmnZps3XQWJl2zU1hKBtjrejZnnjxFT3m-Va5nvJvzdkB9u0o_OXAU53RuHkAauxCu8ph4juHsrV58_0zHcccFi9Inwvj4mEUZKXI8=),\nwill be hosting its Q2-2026 shareholder update call on August 17(th), 2026, at\n5:00 PM ET. The call will include remarks on the company’s current core\nbusinesses, as well as a moderated live Q&A session at the end of the Company\nremarks.\n\n“We are excited to share our upcoming results for Q2. The team continues to\nmake solid progress in adding customers, expanding our pipeline, and growing\nthe business, which will be reflected in our numbers,” said Ilan Danieli,\nCEO.\n\nThis call will incorporate a dedicated moderated live Q&A session into its\nquarterly update call. Management looks forward to addressing investor\nquestions and providing additional insight into the Company’s performance,\nstrategy, and growth initiatives.\n\nFollowing Ilan Danieli’s remarks, the conference call moderator will invite\nlisteners to log into the Q&A system, where they will need to identify\nthemselves and the organization they represent (or individual investor).\nParticipants who wish to ask a question during the live call should follow the\noperator’s instructions.\n\nListeners interested in submitting questions in advance can email their\nquestions to investors@precipiodx.com, and management will do its best to\naddress those questions during the call.\n\nThe conference call may be accessed by calling 646.307.1865. All callers\nshould ask for the Precipio Inc. conference call.\n\nA replay of the call will be available approximately 24 hours after the call\nand may be accessed via the Investors page on Precipio's\nwebsite, https://www.precipiodx.com/investors/.\n\nAbout Precipio\n\nPrecipio is a healthcare biotechnology company focused on cancer diagnostics.\nOur mission is to address the pervasive problem of cancer misdiagnoses by\ndeveloping solutions in the form of diagnostic products and services. Our\nproducts and services deliver higher accuracy, improved laboratory workflow,\nand ultimately better patient outcomes, which reduce healthcare expenses.\nPrecipio develops innovative technologies in our laboratory where we design,\ntest, validate, and use these products clinically, improving diagnostic\noutcomes. Precipio then commercializes these technologies as proprietary\nproducts that serve the global laboratory community and further scales\nPrecipio’s reach to eradicate misdiagnosis.\n\nAvailability of Other Information About Precipio\n\nFor more information, please visit the Precipio website at\nhttps://www.precipiodx.com/ or follow Precipio on X (formerly Twitter)\n(@PrecipioDx) and LinkedIn\n(https://www.globenewswire.com/Tracker?data=e8n8ZFeZbc1sZvHkiRnFA11RP-8eWC4RhTNidlUClZYKKgyuK-3yUQyZaEfdjl5Q8-LCSJ9AvKEKpSjy5wfH462q3pXUAv8Gdkf_5dFrBo0lEQoa5RvhRQBJd9ifdQW8)\n(Precipio) and on Facebook\n(https://www.globenewswire.com/Tracker?data=B84Zli8M7gr18vNvUbinFbWN02-6b8-EP1i9xmiRQhwNmxt4-Zxq_CMRS05n4geZ1mjV2Qh9vjAFRtbIu8VDIx7pQKJplOpwowBxi0-ch0U=).\nInvestors and others should note that we communicate with our investors and\nthe public using our company website (https://www.precipiodx.com), including,\nbut not limited to, company disclosures, investor presentations and FAQs,\nSecurities and Exchange Commission filings, press releases, public conference\ncall transcripts and webcast transcripts, as well as on X and LinkedIn. The\ninformation that we post on our website or on X or LinkedIn could be deemed to\nbe material information. As a result, we encourage investors, the media and\nothers interested to review the information that we post there on a regular\nbasis. The contents of our website or social media shall not be deemed\nincorporated by reference in any filing under the Securities Act of 1933, as\namended.\n\nForward-Looking Statements\n\nThis press release contains “forward-looking statements” within the\nmeaning of Section 27A of the Securities Act of 1933, as amended, and Section\n21E of the Securities Exchange Act of 1934, as amended. All statements\ncontained in this press release that do not relate to matters of historical\nfact should be considered forward-looking statements, including, without\nlimitation, statements regarding the targets set herein and related\ntiming. Except for historical information, statements about future volumes,\nsales, growth, costs, cost savings, margins, earnings, earnings per share,\ndiluted earnings per share, cash flows, adjusted EBITDA, plans, objectives,\nexpectations, growth or profitability and our potential to reach financial\nindependence are forward-looking statements based on management’s estimates,\nbeliefs, assumptions and projections. Words such as “could,” “may,”\n“expects,” “anticipates,” “will,” “targets,” “goals,”\n“projects,” “intends,” “plans,” “believes,” “seeks,”\n“estimates,” “predicts,” and variations on such words, and similar\nexpressions that reflect our current views with respect to future events and\noperational, economic and financial performance, are intended to identify such\nforward-looking statements. These forward-looking statements are only\npredictions based on management’s current expectations. These statements are\nneither promises nor guarantees, but involve known and unknown risks,\nuncertainties and other important factors that may cause our actual results,\nperformance or achievements to be materially different from any future\nresults, performance or achievements expressed or implied by the\nforward-looking statements, including, but not limited to, the important\nfactors discussed under the caption “Risk Factors” in our Annual Report on\nForm 10-K for the fiscal year ended December 31, 2025, and our other reports\nfiled with the U.S. Securities and Exchange Commission. Any such\nforward-looking statements represent management’s estimates as of the date\nof this press release only. While we may elect to update such forward-looking\nstatements at some point in the future, except as required by law, we disclaim\nany obligation to do so, even if subsequent events cause our views to change.\nThese forward-looking statements should not be relied upon as representing our\nviews as of any date subsequent to the date of this press release.\n\nInquiries:\n\ninvestors@precipiodx.com\n\n+1-203-787-7888 Ext. 523\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/d80ae417-b29a-4736-afa2-0f5e3beae51b)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNXCH9pk","title":"Precipio Announces Q2-2026 Shareholder Update Call","author":"Globe Newswire","ticker":"PRPO","created":"2026-07-31T20:00:00.102Z","tickers":["PRPO"],"exchange":"NASDAQ","article_body":"NEW HAVEN, Conn., July 31, 2026 (GLOBE NEWSWIRE) -- Specialty cancer\ndiagnostics company Precipio, Inc.\n(https://www.globenewswire.com/Tracker?data=JIzv5TjhHQvDJRqmKR07o2JyQAJlnCigcFgzVo-RZPjscKB9n7Vy5ZJZ-0ZNZXbnLXCepj68EdRCyV8nRlR1wWhloPZOME0efJDddtf_SrQ=) (NASDAQ:\nPRPO)\n(https://www.globenewswire.com/Tracker?data=TkyaefmnZps3XQWJl2zU1hKBtjrejZnnjxFT3m-Va5nvJvzdkB9u0o_OXAU53RuHkAauxCu8ph4juHsrV58_0zHcccFi9Inwvj4mEUZKXI8=),\nwill be hosting its Q2-2026 shareholder update call on August 17(th), 2026, at\n5:00 PM ET. The call will include remarks on the company’s current core\nbusinesses, as well as a moderated live Q&A session at the end of the Company\nremarks.\n\n“We are excited to share our upcoming results for Q2. The team continues to\nmake solid progress in adding customers, expanding our pipeline, and growing\nthe business, which will be reflected in our numbers,” said Ilan Danieli,\nCEO.\n\nThis call will incorporate a dedicated moderated live Q&A session into its\nquarterly update call. Management looks forward to addressing investor\nquestions and providing additional insight into the Company’s performance,\nstrategy, and growth initiatives.\n\nFollowing Ilan Danieli’s remarks, the conference call moderator will invite\nlisteners to log into the Q&A system, where they will need to identify\nthemselves and the organization they represent (or individual investor).\nParticipants who wish to ask a question during the live call should follow the\noperator’s instructions.\n\nListeners interested in submitting questions in advance can email their\nquestions to investors@precipiodx.com, and management will do its best to\naddress those questions during the call.\n\nThe conference call may be accessed by calling 646.307.1865. All callers\nshould ask for the Precipio Inc. conference call.\n\nA replay of the call will be available approximately 24 hours after the call\nand may be accessed via the Investors page on Precipio's\nwebsite, https://www.precipiodx.com/investors/.\n\nAbout Precipio\n\nPrecipio is a healthcare biotechnology company focused on cancer diagnostics.\nOur mission is to address the pervasive problem of cancer misdiagnoses by\ndeveloping solutions in the form of diagnostic products and services. Our\nproducts and services deliver higher accuracy, improved laboratory workflow,\nand ultimately better patient outcomes, which reduce healthcare expenses.\nPrecipio develops innovative technologies in our laboratory where we design,\ntest, validate, and use these products clinically, improving diagnostic\noutcomes. Precipio then commercializes these technologies as proprietary\nproducts that serve the global laboratory community and further scales\nPrecipio’s reach to eradicate misdiagnosis.\n\nAvailability of Other Information About Precipio\n\nFor more information, please visit the Precipio website at\nhttps://www.precipiodx.com/ or follow Precipio on X (formerly Twitter)\n(@PrecipioDx) and LinkedIn\n(https://www.globenewswire.com/Tracker?data=e8n8ZFeZbc1sZvHkiRnFA11RP-8eWC4RhTNidlUClZYKKgyuK-3yUQyZaEfdjl5Q8-LCSJ9AvKEKpSjy5wfH462q3pXUAv8Gdkf_5dFrBo0lEQoa5RvhRQBJd9ifdQW8)\n(Precipio) and on Facebook\n(https://www.globenewswire.com/Tracker?data=B84Zli8M7gr18vNvUbinFbWN02-6b8-EP1i9xmiRQhwNmxt4-Zxq_CMRS05n4geZ1mjV2Qh9vjAFRtbIu8VDIx7pQKJplOpwowBxi0-ch0U=).\nInvestors and others should note that we communicate with our investors and\nthe public using our company website (https://www.precipiodx.com), including,\nbut not limited to, company disclosures, investor presentations and FAQs,\nSecurities and Exchange Commission filings, press releases, public conference\ncall transcripts and webcast transcripts, as well as on X and LinkedIn. The\ninformation that we post on our website or on X or LinkedIn could be deemed to\nbe material information. As a result, we encourage investors, the media and\nothers interested to review the information that we post there on a regular\nbasis. The contents of our website or social media shall not be deemed\nincorporated by reference in any filing under the Securities Act of 1933, as\namended.\n\nForward-Looking Statements\n\nThis press release contains “forward-looking statements” within the\nmeaning of Section 27A of the Securities Act of 1933, as amended, and Section\n21E of the Securities Exchange Act of 1934, as amended. All statements\ncontained in this press release that do not relate to matters of historical\nfact should be considered forward-looking statements, including, without\nlimitation, statements regarding the targets set herein and related\ntiming. Except for historical information, statements about future volumes,\nsales, growth, costs, cost savings, margins, earnings, earnings per share,\ndiluted earnings per share, cash flows, adjusted EBITDA, plans, objectives,\nexpectations, growth or profitability and our potential to reach financial\nindependence are forward-looking statements based on management’s estimates,\nbeliefs, assumptions and projections. Words such as “could,” “may,”\n“expects,” “anticipates,” “will,” “targets,” “goals,”\n“projects,” “intends,” “plans,” “believes,” “seeks,”\n“estimates,” “predicts,” and variations on such words, and similar\nexpressions that reflect our current views with respect to future events and\noperational, economic and financial performance, are intended to identify such\nforward-looking statements. These forward-looking statements are only\npredictions based on management’s current expectations. These statements are\nneither promises nor guarantees, but involve known and unknown risks,\nuncertainties and other important factors that may cause our actual results,\nperformance or achievements to be materially different from any future\nresults, performance or achievements expressed or implied by the\nforward-looking statements, including, but not limited to, the important\nfactors discussed under the caption “Risk Factors” in our Annual Report on\nForm 10-K for the fiscal year ended December 31, 2025, and our other reports\nfiled with the U.S. Securities and Exchange Commission. Any such\nforward-looking statements represent management’s estimates as of the date\nof this press release only. While we may elect to update such forward-looking\nstatements at some point in the future, except as required by law, we disclaim\nany obligation to do so, even if subsequent events cause our views to change.\nThese forward-looking statements should not be relied upon as representing our\nviews as of any date subsequent to the date of this press release.\n\nInquiries:\n\ninvestors@precipiodx.com\n\n+1-203-787-7888 Ext. 523\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/d80ae417-b29a-4736-afa2-0f5e3beae51b)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-07-31T20:00:00.154347978Z","server_sent_at_ms":1785528000154},"received_at":"2026-07-31T20:00:00.205Z","source_url":null},"analysis":{"id":"94434","press_release_id":"105416","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Precipio announced it will host a Q2 2026 shareholder update call on August 17, 2026, at 5:00 PM ET.\n\nCEO Ilan Danieli stated that the team continues to make solid progress in adding customers and expanding the pipeline, suggesting that business growth will be reflected in the upcoming quarterly results.\n\nThe event will include a moderated live Q&A session, allowing investors to ask questions regarding the company's performance and strategy.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine logistical announcement of Q2 conference call; no data released."},"keyFigures":{},"quotedText":"We are excited to share our upcoming results for Q2. The team continues to make solid progress in adding customers, expanding our pipeline, and growing the business, which will be reflected in our numbers,” said Ilan Danieli,\nCEO.","namedEntities":{"people":[{"name":"Ilan Danieli","role":"CEO"}],"products":[],"companies":[{"name":"Precipio, Inc.","ticker":"PRPO"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine logistical announcement of a future conference call with no financial results or specific operational metrics released."},"tickerRelevance":{"others":[],"primary":"PRPO"},"globalImportance":5,"audienceRelevance":5,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"micro-cap","eventGravity":"logistical_update"}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Precipio announced it will host a Q2 2026 shareholder update call on August 17, 2026, at 5:00 PM ET.\n\nCEO Ilan Danieli stated that the team continues to make solid progress in adding customers and expanding the pipeline, suggesting that business growth will be reflected in the upcoming quarterly results.\n\nThe event will include a moderated live Q&A session, allowing investors to ask questions regarding the company's performance and strategy.","key_figures":{},"named_entities":{"people":[{"name":"Ilan Danieli","role":"CEO"}],"products":[],"companies":[{"name":"Precipio, Inc.","ticker":"PRPO"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-07-31T20:04:02.226Z","global_importance":5,"audience_relevance":5,"importance_components":{"tickerTier":"micro-cap","eventGravity":"logistical_update"}},"durationMs":180338,"modelName":"glm-4.7"}}